Apheresis platelets: Emerging issues related to donor platelet count, apheresis platelet yield platelet transfusion dose

Lawrence Tim Goodnough, David Kuter, Jeffrey McCullough, Mark E. Brecher

Research output: Contribution to journalArticlepeer-review

31 Scopus citations

Abstract

Emerging issues in stimulating apheresis platelet donors with platelet growth factors, the relative costs of apheresis and random donor platelet concentrates, optimal platelet transfusion dose, and leucoreduction of platelet products have caused renewed debate regarding apheresis products rs. random, pooled concentrates. The future role of apheresis products in platelet transfusion therapy will in large part be determined by costs, which are increasingly recognized to be influenced by donor platelet count, apheresis yield, and platelet transfusion dose.

Original languageEnglish (US)
Pages (from-to)114-119
Number of pages6
JournalJournal of clinical apheresis
Volume13
Issue number3
DOIs
StatePublished - Nov 17 1998

Keywords

  • Apheresis platelets
  • Donor platelet count
  • Platelet transfusion therapy

Fingerprint

Dive into the research topics of 'Apheresis platelets: Emerging issues related to donor platelet count, apheresis platelet yield platelet transfusion dose'. Together they form a unique fingerprint.

Cite this